Heart of the matter: can a pill fix blood vessels in kidney disease?
NCT ID NCT04930549
Summary
This study tested whether a 12-week course of the drug dapagliflozin, which is usually for diabetes, could improve blood vessel health in people with chronic kidney disease who do not have diabetes. It involved 32 patients who were randomly assigned to receive either the drug or a placebo pill. The main goal was to see if the drug made blood vessels more flexible and responsive, which could help protect the heart and kidneys.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Nephrology
Bois-Guillaume, 76230, France
-
Department of Pharmacology
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.